Skip to main content
Premium Trial:

Request an Annual Quote

Sidec Closes $10.2M Private-Equity Round

NEW YORK (GenomeWeb News) — Sidec Technologies today said it has netted SEK 68.5 million ($10.2 million) in a round of venture-capital funding from new and existing investors.
 
The company said it plans to use the money to build its sales and marketing programs and fund research.  
 
The funding round was led by Earlybird Venture Capital, Swedish Investor Growth Capital, and Industrifonden, the company said.
 
Stockholm-based Sidec sells a 3D cellular-imaging product to pharmaceutical clients.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more